Drug development for asthma

American Journal of Respiratory Cell and Molecular Biology

Volumn 29, Issue 2, 2003, Pages 163-171

  Holtzman, Michael J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CYTOKINE; DNA VACCINE; FLUTICASONE; GLUCOCORTICOID; IMMUNOGLOBULIN E; INTERFERON; MONOCLONAL ANTIBODY; OMALIZUMAB; PHOSPHODIESTERASE IV INHIBITOR; RAMATROBAN; SALMETEROL; THEOPHYLLINE; TRANSCRIPTION FACTOR;

AIRWAY; ALLERGY; ANAPHYLAXIS; ASTHMA; BRONCHUS HYPERREACTIVITY; CELL ACTIVATION; CLINICAL TRIAL; DRUG ACTIVITY; DRUG MECHANISM; DRUG TARGETING; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; INFLAMMATION; PATHOGENESIS; PHENOTYPE; REVIEW; SENSITIZATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH2 CELL;

ANTI-INFLAMMATORY AGENTS; ASTHMA; BINDING SITES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN E; IMMUNOTHERAPY; MODELS, BIOLOGICAL; T-LYMPHOCYTES; TH2 CELLS; VACCINES, DNA;

BRONCHUS;

EID: 0042201864     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.F276     Document Type: Review

References (74)

1. Holtzman, M. J., J. D. Morton, L. P. Shornick, J. W. Tyner, M. P. O'Sullivan, A. Antao, M. Lo, M. Castro, and M. J. Walter. 2002. Immunity, inflammation, and remodeling in the airway epithelial barrier: epithelial-viral-allergic paradigm. Physiol. Rev. 82:19-46.
2. Grayson, M. H., and M. J. Holtzman, 2002. Lessons from allergic rhinitis versus asthma pathogenesis and treatment. Immunol. Allergy Clin. North Am. 22:845-869.
3. Holtzman, M. J. 2003. Where are the gaps in asthma research? A counter-perspective. J. Allergy Clin. Immunol. 111:244-247.
4. Holtzman, M. J., E. Agapov, E. Kim, J. Kim, and J. D. Morton. 2003. Developing the epithelial, viral, and allergic paradigm for asthma. Chest 123:377S-384S.
5. Vanacker, N. J., E. Palmans, R. A. Pauwels, and J. C. Kips. 2002. Effect of combining salmeterol and fluticasone on the progression of airway remodeling. Am. J. Respir. Crit. Care Med. 166:1128-1134.
6. Baramki, D., J. Koester, A. J. Anderson, and L. Borish. 2002. Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J. Allergy Clin. Immunol. 109:449-454.
7. Keir, S., C. Page, and D. Spina. 2002. Bronchial hyperresponsiveness induced by chronic treatment with albuterol: role of sensory nerves. J. Allergy Clin. Immunol. 110:388-394.
8. Weinbrenner, A., D. Huneke, M. Zschiesche, G. Engle, W. Timmer, V. W. Steinijans, T. Bethke, W. Wurst, A. Drollmann, H. J. Kaatz, and W. Siegmund. 2002. Circadidan rhythm of serum cortisol after repeated inhlation of the new topcial steroid ciclesonide. J. Clin. Endocrinol. Metab. 87:2160-2163.
9. Bledsoe, R. K., V. G. Montana, T. B. Stanley, C. J. Delves, C. J. Apolilto, D. D. McKee, T. G. Consler, D. J. Parks, E. L. Stewart, T. M. Willson, M. H. Lambert, J. J. Moore, K. H. Pearce, and H. E. Xu. 2002. Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110:93-105.
10. Ferreira, F., K. Hirtenlehner, A. Jilek, J. Godnik-Cvar, H. Breiteneder, R. Grimm, K. Hoffmann-Sommergruber, O. Sheiner, D. Kraft, M. Breitenbach, H.-J, Rheinberger, and C. Ebner. 1996. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J. Exp. Med. 183:599-609.
11. Breiteneder, H., F. Ferreira, K. Hoffmann-Sommergruber, C. Ebner, M. Breitenbach, H. Rumpold, D. Kraft, and O. Scheiner. 1993. Four recombinant isoforms of Cor a I, the major allergen of hazel pollen, show different IgE-binding poperties. Eur. J. Biochem. 212:355-362.
12. Norman, P. S., J. L. Ohman, Jr., A. A. Long, P. S. Creticos, M. A. Gefter, Z. Shaked, R. A. Wood, P. A. Eggleston, K. B. Hafner, P. Rao, L. M. Lichtenstein, N. H. Jones, and C. F. Nicodemus. 1996. Treatment of cat allergy with T-cell reactive peptides. Am. J. Respir. Crit. Care Med. 154:1623-1628.
13. Haselden, B. M., A. B. Kay, and M. Larche. 1999. Immunoglobulin E-independent major histocompatibility complex-restricted Tcell peptide epitope-induced late asthmatic reactions. J. Exp. Med. 189:1885-1894.
14. Texier, C., S. Pouvelle, M. Busson, M. Herve, D. Charron, A. Menez. and B. Maillere. 2000. HLA-DR restricted peptide candidates for bee venom immunotherapy. J. Immunol. 164:3177-3184.
15. Tighe, H., M. Corr, M. Roman, and E. Raz. 1998. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol. Today 19:89-97.
16. Hasan, U. A., A. M. Abai, D. R. Harper, B. W. Wren, and W. J. W. Morrow. 1999. Nucleic acid immunization: concepts and techniques associated with third generation vaccines. J. Immunol. Methods 229:1-22.
17. Allsopp, C. E., M. Plebanski, S. Gilbert, R. E. Sinden, S. Harris, G. Frankel, G. Dougan, C. Hioe, D. Nixon, E. Paoletti, G. Layton, and A. V. S. Hill. 1996. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur. J. Immunol. 26:1951-1959.
18. Roy, K., H. Q. Mao, S. K. Huang, and K. W. Leong. 1999. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat. Med 5:387-393.
19. Abramson, M. J., R. M. Puy, and J. J. Weiner. 1995. Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials. Am. J. Respir. Crit. Care Med. 151:969-974.
20. Adkinson, N. F., Jr., P. A. Eggleston, D. Eney, E. O. Goldstein, K. C. Schuberth, J. R. Bacon, R. G. Hamilton, M. E. Weiss, H. Arshad, C. L. Meinert, J. Tonascia, and B. Wheeler. 1997. A controlled trial of immunotherapy for asthma in allergic children. N. Engl. J. Med. 336:324-331.
21. Creticos, P., C. E. Reed, P. S. Norman, J. Khoury, N. F. Adkinson, Jr., C. R. Buncher, W. W. Busse, R. K. Bush, J. Gadde, J. T. Li, H. B. Richerson, R. R. Rosenthal, W. R. Solomon, P. Steinberg, and J. W. Yunginger. 1996. Ragweed immunotherapy in adult asthma. N. Engl. J. Med. 334:501-506.
22. Bach, J.-F. 2002. Mechanisms of disease: the effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med. 347:911-920.
23. Braun-Fahrlander, C., J. Riedler, U. Herz, W. Eder, M. Waser, L. Grize, S. Maisch, D. Carr, F. Gerlach, A. Bufe, R. P. Lavener, R. Schierl, H. Renz, D. Nowak, and E. von Mutius. 2002. Environmental exposure to endotoxin and its relation to asthma in school-age children. N. Engl. J. Med. 347:869-877.
24. Silverman, E. S., and J. M. Drazen. 2003. Immunostimulatory DNA for asthma: better than eating dirt. Am. J. Respir. Cell Mol. Biol. (In press)
25. Carson, D. A., and E. Raz. 1997. Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination. J. Exp. Med 186:1621-1622.
26. Chu, R. S., O. S. Targoni, A. M. Krieg, P. V. Legmann, and C. V. Harding. 1997. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1623 1631.
27. Kline, J. N., K. Kitagaki, T. R. Businga, and V. V. Jain. 2002. Treatment of established asthma in a murine model using CpG oligonucleotides. Am. J. Physiol. 283:L170-L179.
28. Boguniewicz, M., R. J. Martin, D. Martin, U. Gibson, A. Celniker, M. Williams, and D. Y. M. Leung, 1995. The effects of nebulized recombinant interferon-γ in asthmatic airways. J. Allergy Clin. Immunol. 95:133-135.
29. Gratzi, S., A. Palca, M. Schmitz, and H.-U. Simon. 2000. Treatment with IFN-α in corticosteroid-unresponsive asthma. J. Allergy Clin. Immunol. 105:1035-1037.
30. Bryan, S. A., B. J. O'Connor, S. Matti, M. J. Leckie, V. Kanabar, J. Khan, S. J. Warrington, L. Renzetti, A. Rames, J. A. Bock, M. J. Boyce, T. T. Hansel, S. T. Holgate, and P. J. Barnes. 2000. Effects of recombinant human interleukin-12 on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356:2149-2153.
31. Holtzman, M. J., D. Sampath, M. Castro, D. C. Look, and S. Jayaraman. 1996. The one-two of T helper cells: does interferon-γ knockout the Th2 hypothesis for asthma? Am. J. Respir. Cell Mol. Biol. 14:316-318.
32. Sampath, D., M. Castro, D. C. Look, and M. J. Holtzman. 1999. Constitutive activation of an epithelial signal transducer and activator of transcription (Stat1) pathway in asthma. J. Clin. Invest. 103:1353-1361.
33. Walter, M. J., N. Kajiwara, P. Karanja, M. Castro. and M. J. Holtzman. 2001. IL-12 p40 production by barrier epithelial cells during airway inflammation. J. Exp. Med. 193:339-352.
34. Stephens, R., D. A. Randolph, G. Huang, M. J. Holtzman, and D. D. Chaplin, 2002. Antigen-nonspecific recruitment of Th2 cells to the lung as a mechanism for viral infection-induced allergic asthma. J. Immunol. 169:5458-5467.
35. MacGlashan, D. W., B. S. Bochner, D. C. Adelman, P. M. Jardieu, A. Togias, J. McKenzie-White, S. A. Sterbinsky, R. G. Hamilton, and L. M. Lichteustein. 1997. Down-regulation of FcεRI expression on human basophils during an in vivo treatment of atopic patients with anti-IgE antibody. J. Immunol. 158:1438-1445.
36. Casale, T. B., I. L. Bernstein, W. W. Busse, C. F. LaForce, D. G. Tinkelman, R. R. Stoltz, R. J. Dockhorn, J. Reimann, J. Q, Su, R. B. Fick, Jr., and D. C. Adelman. 1997. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J. Allergy Clin. Immunol. 100:110-121.
37. Milgrom, H., R, B. Fick, Jr., J. Q. Su, J. D. Reimann, R. K. Bush, M. L. Watrous, and W. J. Metzger. 1999. Treatment of allergic asthma with monoclonal anti-IgE antibody. N. Engl. J. Med. 341:1966-1973.
38. Boulet, L.-P., K. R. Chapman, J. Cote, S. Kalra, R. Bhagat, V. A. Swystun, M. Laviolette, L. D. Cleland, F. Deschesnes, J. Q. Su, A. DeVault, R. B. Fick, Jr., and D. W. Cockcroft. 1997. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response. Am. J. Respir. Crit. Care Med. 155:1835-1840.
39. Fahy, J. V., H. E. Fleming, H. H. Wong, J. T. Liu, J. Q. Su, J. Reimann, R. B. Fick, Jr., and H. A. Boushey. 1997. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects. Am. J. Respir. Crit. Care Med. 155:1828-1834.
40. Busse, W., J. Corren, B. Q. Lanier, M. McAlary, A. Fowler-Taylor, G. D. Cioppa, A. van As, and N. Gupta. 2001. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe asthma. J. Allergy Clin. Immunol. 108:184-190.
41. Mehlhop, P. D., M. van de Ruin, A. B. Goldberg, J. P. Brewer, V. P. Kurup, T. R. Martin, and H. C. Oettgen. 1997. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc. Natl. Acad. Sci. USA 94:1344-1349.
42. Borish, L. C., H. S. Nelson, M. J. Lanz, L. Claussen, J. B. Whitmore, J. M. Agosti, and L. Garrison. 1999. Interleukin-4 receptor in moderate atopic asthma: a phase I/II randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 160:1816-1823.
43. Ryan, J. J. 1997. Interleukin-4 and its receptor: essential mediators of the allergic reponse. J. Allergy Clin. Immunol. 99:1-5.
44. Burr, J. S., S. L. Kimzey, D. R. Randolph, and J. M. Green. 2002. CD28 and CTLA4 coordinately regulate airay inflammatory cell recruitment and T-helper. Am. J. Respir. Cell Mol. Biol. 24:563-568.
45. Green, J. M., V. Karpitskiy, S. L. Kimzey, and A. S. Shaw. 2000. Coordinate regulation of T cell activation by CD2 and CD28. J. Immunol. 164:3591-3595.
46. + T cells. Nat. Immunol. 3:549-557.
47. Finotto, S., N. F. Neurath, J. N. Glickman, S. Qin, H. A. Lehr, F. H. Y. Green, K. Ackerman, K. Haley, P. R. Galle, S. J. Szabo, J. M. Drazen, G. T. De Sanctis, and L. H. Glimcher. 2002. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science 295:336-338.
48. H1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295:338-342.
49. O'Sullivan, S., L. Cormican, J. L. Faul, S. Ichinohe, S. L. Johnston, C. M. Burke, and L. W. Poulter. 2001. Activated, cytotoxic CD8+ T lymphocytes contribute to the pathology of asthma death. Am. J. Respir. Crit. Care Med. 164:560-564.
50. + T cells and atopic disease. J. Clin. Invest. 110:1283-1291.
51. Holtzman, M. J., E. Y. Kim, and J. D. Morton. 2003. Genetic and genomic approaches to complex lung diseases using mouse models. In Computational Genetics and Genomics: Tools for Understanding Complex Disease. G. Peltz, editor. Humana Press Inc, Totawa, NJ. (In press)
52. Mauser, P. J., A. M. Pitman, X. Fernandez, S. K. Foran, G. K. Adams, W. Kreumer, R. W. Egan, and R. W. Chapman. 1995. Effects of an antibody to interleukin-5 in a monkey model of asthma. Am. J. Respir. Crit. Care Med. 152:467-472.
53. Leckie, M. J., A. ten Brinke, J. Khan, Z. Diamant, B. J. O'Connor, C. M. Walls, A. K. Mathur, H. C. Cowley, K. P. Chung, R. Djukanovic, T. T. Hansel, S. T. Holgate, P. J. Stork, and P. J. Barnes. 2000. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 356:2144-2148.
54. Flood-Page, P. T., A. N. Menzies-Gow, A. B. Kay, and D. S. Robinson. 2003. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am. J. Respir. Crit. Care Med. 167:199-204.
55. McKenzie, A. N. J., and P. G. Fallon. 2003. Decoy receptors in the regulation of T helper cell type 2 responses. J. Exp. Med. 197:675-679.
56. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282:2258-2261.
57. Reader, J. R., D. M. Hyde, E. S. Schelegle, M. C. Aldrich, A. M. Stoddard, M. P. McLane, R. C. Levitt, and J. S. Tepper. 2003. IL-9 induces mucous cell metaplasia independent of inflammation. Am. J. Respir. Cell Mol. Biol. (In press)
58. Walter, M. J., J. D. Morton, N. Kajiwara, E. Agapov, and M. J. Holtzman. 2002. Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J. Clin. Invest. 110:165-175.
59. Economides, A. N, L. R. Carpenter, J. S. Rudge, V. Wong, E. M. Koehler-Stec, C. Hartnett, E. A. Pyles, X. Xu, T. J. Daly, M. R. Young, J. P. Fandl, F. Lee, S. Carver. J. McNay, K. Bailey, S. Ramakanth, R. Hutabarat, T. T. Huang, C. Radziejewski, G. D. Yancopoulos, and N. Stahl. 2003. Cytokine traps: multi-component, high-affinity blockers of cytokine action. Nat. Med. 9:47-52.
60. Ma, W., P. J. Bryce, A. A. Humbles, D. Laouini, A. Yalcindag, H. Alenius, D. S. Friend, H. C. Oettgen, C. Gerard, and R. S. Geha. 2002. CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation. J. Clin. Invest. 109:621-628.
61. Humbles, A. A., B. Lu, D. S. Friend, S. Okinaga, J. Lora, A. Al-garawi, T. R. Martin, N. P. Gerard, and C. Gerard. 2002. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc. Natl. Acad. Sci. USA. 99:1479-1784.
62. Panina-Bordignon, P., A. Papi, M. Mariani, P. Di Lucia, G. Casoni, C. Bellettato, C. Buonsanti, D. Miotto, C. Mapp, A. Villa, G. Arrigoni, L. M. Fabbri and F. Sinigaglia. 2001. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J. Clin. Invest. 107:1357-1364.
63. Forsythe, P., and A. D. Befus. 2002. CCR3. A key to mast cell phenotype and functional diversity? Am. J. Respir. Cell Mol. Biol. 28:405-409.
64. Miller, D. H., O. A. Khan, W. A. Sheremata, L. D. Blumhardt, G. P. A. Rice, M. A. Libonati, A. J. Willmer-Hulme, C. M. Dalton, K. A. Miszkiel, and P. W. O'Connor. 2003. A controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 348:15-23.
65. 2 receptor, CRTH2. J. Immunol. 168:981-985.
66. Barnett, M. S. 1999. Phosphodiesterase 4 (PDE4) inhibitors in asthma and chronic obstructive pulmonary disease. Prog. Drug Res. 53:193-229.
67. Brightling, C. E., P. Bradding, F. A. Symon, S. T. Holgate, A. J. Wardlaw, and I. D. Pavord. 2002. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 346:1699-1705.
68. Karp, C. L., A. Grupe, E. Schadt, S. L. Ewart, M. Keane-Moore, P. J. Cuomo, J. Kohl, L. Wahl, D. Kuperman, S. Germer, D. Aud, G. Peltz, and M. Wills-Karp. 2000. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nat. Immunol. 1:221-226.
69. Humbles, A. A., B. Lu, C. A. Nilsson, C. Lilly, E. Israel, Y. Fujiwara, N. P. Gerard, and C. Gerard. 2000. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406:998-1001.
70. Van Eerdewegh, P., R. D. Little, J. Dupuis, R. G. Del Mastro, K. Falls, J. Simon, D. Torrey, S. Pandit, J. McKenny, K. Braunschweiger, A. Walsh, Z. Liu, and B. Hayward. 2002. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 418:426-430.
71. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. C. Locksley. 1995. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109-117.
72. Melhop, P. D., M. van de Rijn, A. B. Goldberg, J. P. Brewer, V. P. Kurup, T. R. Martin, and H. C. Oettgen. 1997. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. Proc. Natl. Acad. Sci. USA 94:1344-1349.
73. Hakonarson, H., U. S. Bjornsdottir, E. Ostermann, T. Arnason, A. E. Adalsteinsdottir, E. Halapi, D. Shkolny, K. Kristjansson, S. A. Gudnadottir, M. L. Frigge, D. Gislason, T. Gislason, A. Kong, J. Gulcher, and K. Stefansson. 2001. Allelic frequencies and patterns of single-nucleotide polymorphisms in candidate genes for asthma and atopy in Iceland. Am. J. Respir. Crit. Care Med. 164:2036-2044.
74. Taguchi, M., D. Sampath, T. Koga, M. Castro, D. C. Look, S. Nakajima, and M. J. Holtzman. 1998, Patterns for RANTES secretion and intercellular adhesion molecule-1 expression mediate transepithelial T cell traffic based on analyses in vitro and in vivo. J. Exp. Med. 187:1927-1940.